Applied Therapeutics, Inc.

NasdaqGM:APLT Stock Report

Market Cap: US$66.7m

Applied Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqGM:APLT Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
04 Mar 25SellUS$197Constantine ChinoporosIndividual447US$0.44
04 Mar 25SellUS$6,381Les FuntleyderIndividual14,502US$0.44
04 Mar 25SellUS$4,561Riccardo PerfettiIndividual10,366US$0.44
06 Feb 25SellUS$14,000Les FuntleyderIndividual22,950US$0.61
06 Feb 25SellUS$52,508Riccardo PerfettiIndividual86,078US$0.61
06 Feb 25SellUS$17,151Constantine ChinoporosIndividual28,117US$0.61
22 Aug 24SellUS$132,230Riccardo PerfettiIndividual22,681US$5.83
22 Aug 24SellUS$78,880Les FuntleyderIndividual13,530US$5.83
14 Aug 24SellUS$4,712,049Shoshana ShendelmanIndividual777,014US$6.18
06 Jun 24SellUS$95,053Riccardo PerfettiIndividual22,003US$4.32
06 Jun 24SellUS$73,354Les FuntleyderIndividual16,980US$4.32
06 Jun 24SellUS$266,954Shoshana ShendelmanIndividual61,795US$4.32
05 Jun 24SellUS$1,267,500Alexandria Venture Investments, LLCCompany300,000US$4.24

Insider Trading Volume

Insider Buying: APLT insiders have only sold shares in the past 3 months.

Ownership Breakdown

What is the ownership structure of APLT?
Owner TypeNumber of SharesOwnership Percentage
Private Companies1,580,4911.3%
Individual Insiders6,846,5815.62%
VC/PE Firms16,049,64513.2%
Hedge Funds20,262,29116.6%
Institutions77,086,68263.3%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 91.77% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
9.88%
Vestal Point Capital, LP
11,500,000US$6.6m904%0.37%
8.59%
VR Adviser, LLC
9,990,591US$5.7m1.69%0.45%
7.99%
BlackRock, Inc.
9,296,075US$5.3m33.9%no data
7.53%
Schonfeld Strategic Advisors LLC
8,762,291US$5.0m2,460%0.03%
5.84%
Propel Bio Management, LLC
6,797,915US$3.9m3.5%11.04%
5.21%
Alexandria Venture Investments, LLC
6,059,054US$3.5m0%100.0%
4.98%
Knoll Capital Management
5,799,687US$3.3m4.04%2.04%
4.77%
The Vanguard Group, Inc.
5,548,231US$3.2m5.82%no data
4.69%
T. Rowe Price Group, Inc.
5,455,683US$3.1m344%no data
3.91%
Shoshana Shendelman
4,548,236US$2.6m0%no data
3.84%
Deutsche Asset & Wealth Management
4,468,122US$2.6m0.69%no data
2.46%
Morgan Stanley, Investment Banking and Brokerage Investments
2,858,931US$1.6m-67.6%no data
2.42%
Simplify Asset Management Inc.
2,817,505US$1.6m0%0.07%
2.33%
Alyeska Investment Group, L.P.
2,707,497US$1.6m176%0.01%
2.09%
Tang Capital Management, LLC
2,428,169US$1.4m-11.1%0.08%
1.79%
Geode Capital Management, LLC
2,084,142US$1.2m-0.36%no data
1.78%
State Street Global Advisors, Inc.
2,066,336US$1.2m-44.1%no data
1.72%
Franklin Resources, Inc.
2,003,338US$1.1m-70.5%no data
1.69%
Adage Capital Management, L.P.
1,961,629US$1.1m-52.3%no data
1.68%
Qube Research & Technologies Ltd
1,950,521US$1.1m15,700%no data
1.65%
Rock Springs Capital Management LP
1,917,191US$1.1m9.78%0.04%
1.4%
Invus Financial Advisors, LLC
1,633,768US$936.3k0%0.05%
1.28%
Sycamore Family LLC
1,492,094US$855.1k0%no data
1.14%
Millennium Management LLC
1,329,149US$761.7k379%no data
1.12%
Marshall Wace LLP
1,307,381US$749.3k145%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/03/23 01:28
End of Day Share Price 2025/03/21 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Applied Therapeutics, Inc. is covered by 11 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Brian SkorneyBaird
Carter GouldBarclays
Catherine SeifertCFRA Equity Research